Jun Yang

16PUBLICATIONS
95CO-AUTHORS
Tissue engineeringMolecular targetsHaematological tumoursMetabolic medicineCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 06, 2025
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

Jie Fang, Shivendra Singh, Brennan Wells

|Nov 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma.

Tingting Wang, Lingling Liu, Jie Fang

|Apr 27, 2024
Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro.

William A Chen, Terry G Williams, Leena So

|Mar 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor.

Carolyn M Jablonowski, Waise Quarni, Shivendra Singh

|Feb 05, 2024
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway.

Jun Yang

|Feb 05, 2024
Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma.

Xiaofeng Wu, Menchus Quan, Marco Hadisurya

Pageof 3

Frequent Collaborators

6 joint publications

Ruoning Wang

6 joint publications

Andrew Murphy

4 joint publications

Andrew M Davidoff

4 joint publications

Jie Fang